These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 14662715)

  • 1. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.
    Juul K; Tybjaerg-Hansen A; Marklund S; Heegaard NH; Steffensen R; Sillesen H; Jensen G; Nordestgaard BG
    Circulation; 2004 Jan; 109(1):59-65. PubMed ID: 14662715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetically determined reduction in antioxidative protection and increased risk of ischemic heart disease--secondary publication].
    Juul K; Tybjaerg-Hansen A; Marklund S; Heegaard NH; Steffensen R; Sillesen HH; Jensen GB; Nordestgaard BG
    Ugeskr Laeger; 2005 Feb; 167(7):767-70. PubMed ID: 15779264
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease.
    Stene MC; Frikke-Schmidt R; Nordestgaard BG; Grande P; Schnohr P; Tybjaerg-Hansen A
    J Am Coll Cardiol; 2008 Jul; 52(5):369-77. PubMed ID: 18652945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study.
    Ellervik C; Tybjaerg-Hansen A; Grande P; Appleyard M; Nordestgaard BG
    Circulation; 2005 Jul; 112(2):185-93. PubMed ID: 15998685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.
    Juul K; Tybjaerg-Hansen A; Marklund S; Lange P; Nordestgaard BG
    Am J Respir Crit Care Med; 2006 Apr; 173(8):858-64. PubMed ID: 16399992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
    Wittrup HH; Andersen RV; Tybjaerg-Hansen A; Jensen GB; Nordestgaard BG
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1438-45. PubMed ID: 16418216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular disease.
    Hornstrup LS; Tybjærg-Hansen A; Haase CL; Nordestgaard BG; Sillesen H; Grande P; Frikke-Schmidt R
    Circ Cardiovasc Genet; 2011 Oct; 4(5):534-41. PubMed ID: 21831958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals.
    Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
    Pharmacogenomics J; 2009 Oct; 9(5):327-32. PubMed ID: 19652664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population.
    Frikke-Schmidt R; Nordestgaard BG; Schnohr P; Steffensen R; Tybjaerg-Hansen A
    J Am Coll Cardiol; 2005 Oct; 46(8):1516-20. PubMed ID: 16226177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alcohol consumption, S-LDL-cholesterol and risk of ischemic heart disease. 6-year follow-up in The Copenhagen Male Study].
    Hein HO; Suadicani P; Gyntelberg F
    Ugeskr Laeger; 1997 Jun; 159(26):4110-6. PubMed ID: 9229869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin beta3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population.
    Tofteng CL; Bach-Mortensen P; Bojesen SE; Tybjaerg-Hansen A; Hyldstrup L; Nordestgaard BG
    Pharmacogenet Genomics; 2007 Jan; 17(1):85-91. PubMed ID: 17264806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis.
    Faurschou M; Mellemkjaer L; Sorensen IJ; Svalgaard Thomsen B; Dreyer L; Baslund B
    Arthritis Rheum; 2009 Apr; 60(4):1187-92. PubMed ID: 19333952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary hemochromatosis genotypes and risk of ischemic stroke.
    Ellervik C; Tybjaerg-Hansen A; Appleyard M; Sillesen H; Boysen G; Nordestgaard BG
    Neurology; 2007 Mar; 68(13):1025-31. PubMed ID: 17389307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Job categories and acute ischemic heart disease: a hospital-based, case-control study in Taiwan.
    Chen JD; Cheng TJ; Lin YC; Hsiao ST
    Am J Ind Med; 2007 Jun; 50(6):409-14. PubMed ID: 17450543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocytosis of extracellular superoxide dismutase into endothelial cells: role of the heparin-binding domain.
    Chu Y; Piper R; Richardson S; Watanabe Y; Patel P; Heistad DD
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1985-90. PubMed ID: 16809550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does SOD3 R213G Homozygosity Influence Morbidity, Mortality, and Lung Function in the General Population?
    Kobylecki CJ; Afzal S; Nordestgaard BG
    Antioxid Redox Signal; 2016 May; 24(15):884-91. PubMed ID: 26901385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.
    Andersen RV; Wittrup HH; Tybjaerg-Hansen A; Steffensen R; Schnohr P; Nordestgaard BG
    J Am Coll Cardiol; 2003 Jun; 41(11):1972-82. PubMed ID: 12798568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study.
    Tybjaerg-Hansen A; Agerholm-Larsen B; Humphries SE; Abildgaard S; Schnohr P; Nordestgaard BG
    J Clin Invest; 1997 Jun; 99(12):3034-9. PubMed ID: 9185528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.
    Benn M; Nordestgaard BG; Grande P; Schnohr P; Tybjaerg-Hansen A
    J Am Coll Cardiol; 2010 Jun; 55(25):2833-42. PubMed ID: 20579540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients.
    Hailpern SM; Cohen HW; Alderman MH
    Am J Hypertens; 2006 Oct; 19(10):998-1004. PubMed ID: 17027817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.